← Eichor
Condition: Neuromyelitis Optica Spectrum Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Neuromyelitis Optica Spectrum Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
Phase 1 · 1 location(s) · Tongji Hospital · NCT06620809Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD
Phase N/A · 1 location(s) · Tongji Hospital · NCT06885957Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT04106830Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06780709Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT06763848Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Phase N/A · 7 location(s) · Alexion Pharmaceuticals, Inc. · NCT06312644Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte My
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06865274A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Phase 2/Phase 3 · 51 location(s) · Shanghai Jiaolian Drug Research and Development Co., Ltd · NCT06413654Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in
EARLY_Phase 1 · 1 location(s) · Tianjin Huanhu Hospital · NCT06939166Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Phase N/A · 3 location(s) · icometrix · NCT06280755Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
EARLY_Phase 1 · 4 location(s) · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05145361Azathioprine in MOGAD
Phase 3 · 17 location(s) · Hospices Civils de Lyon · NCT05349006Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Phase N/A · 33 location(s) · Alexion Pharmaceuticals, Inc. · NCT05966467Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Phase N/A · 13 location(s) · University of Bern · NCT05017142MS-ResearchBiomarkerS
Phase N/A · 1 location(s) · Cedars-Sinai Medical Center · NCT05204459Ofatumumab in AQP4-IgG Seropositive NMOSD
Phase 1/Phase 2 · 1 location(s) · Tang-Du Hospital · NCT05504694Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT05792462Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT06398158Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optic
NA · 1 location(s) · Tang-Du Hospital · NCT07377305Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous Sys
EARLY_Phase 1 · 1 location(s) · Tongji Hospital · NCT04561557Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Phase 2 · 19 location(s) · Amgen · NCT05549258Analysis of the Role of AIRE in Autoimmune Neurological Diseases Associated With Autoantibodies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06941584Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Media
Phase 1 · 1 location(s) · Tongji Hospital · NCT07526493Biomarkers in Autoimmune Disease of Nervous System
Phase N/A · 1 location(s) · Tongji Hospital · NCT06502015Biorepository and Registry for Plasma Exchange Patients
Phase N/A · 1 location(s) · Charles M Knudson · NCT05004493Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
Phase 3 · 1 location(s) · Tianjin Medical University General Hospital · NCT07420296Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
Phase 4 · 1 location(s) · Chinese PLA General Hospital · NCT07410039Cohort Study on Neuroimmune Diseases in the Reproductive Age
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT07653984
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.